Medicare Enrolled
Dr. Muhammad Ehtesham, M.D.
Pulmonary Disease · Farmington Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ehtesham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ehtesham?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ehtesham
Dr. Muhammad Ehtesham is a pulmonary disease specialist in Farmington Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ehtesham performed 1,193 Medicare services across 922 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ehtesham received a total of $12,684 from 48 pharmaceutical and/or device companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ehtesham is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 29% volume in MI
$12,684 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,193
Medicare services
Top 29% in MI for pulmonary disease
922
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~60 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $64 | $120 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
244 | $173 | $450 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
241 | $91 | $175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
153 | $95 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $121 | $225 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
57 | $64 | $110 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $141 | $270 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
39 | $42 | $125 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
39 | $44 | $125 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
22 | $21 | $75 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
18 | $29 | $150 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
12 | $99 | $375 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $141 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,684
Total received (2018-2024)
Avg $1,812/year across 7 years
Top 11% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
48
Companies
604
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,165 (95.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$519 (4.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,836
2023
$2,220
2022
$1,832
2021
$1,209
2020
$1,679
2019
$2,017
2018
$1,890
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$336
Baxter Healthcare
$189
Regeneron Healthcare Solutions, Inc.
$189
Pulmonx Corporation
$163
GENZYME CORPORATION
$137
Mallinckrodt Hospital Products Inc.
$134
Boehringer Ingelheim Pharmaceuticals, Inc.
$120
Inspire Medical Systems, Inc.
$111
Mylan Specialty L.P.
$78
AstraZeneca Pharmaceuticals LP
$75
United Therapeutics Corporation
$49
Grifols USA, LLC
$46
CSL Behring
$43
Electromed, Inc.
$37
Merck Sharp & Dohme LLC
$28
JAZZ PHARMACEUTICALS INC.
$24
Bayer Healthcare Pharmaceuticals Inc.
$22
Avadel CNS Pharmaceuticals, LLC
$22
Philips North America LLC
$18
Gilead Sciences, Inc.
$15
Top 3 companies account for 38.9% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,549
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,607
Veran Medical Technologies, Inc.
$777
United Therapeutics Corporation
$754
AstraZeneca Pharmaceuticals LP
$665
Mylan Specialty L.P.
$608
Baxter Healthcare
$566
Grifols USA, LLC
$538
Sunovion Pharmaceuticals Inc.
$521
Regeneron Healthcare Solutions, Inc.
$499
Actelion Pharmaceuticals US, Inc.
$366
GENZYME CORPORATION
$333
Pulmonx Corporation
$317
PORTOLA PHARMACEUTICALS, INC.
$184
Mallinckrodt Enterprises LLC
$177
CSL Behring
$162
Electromed, Inc.
$142
Mallinckrodt Hospital Products Inc.
$134
JAZZ PHARMACEUTICALS INC.
$131
Insmed, Inc.
$123
Advanced Respiratory, Inc
$120
Inspire Medical Systems, Inc.
$111
Gilead Sciences, Inc.
$104
Philips Electronics North America Corporation
$100
Merck Sharp & Dohme LLC
$95
HARMONY BIOSCIENCES LLC
$95
Bard Access Systems, Inc.
$94
Mallinckrodt LLC
$92
SANOFI-AVENTIS U.S. LLC
$89
Becton, Dickinson and Company
$88
Teva Pharmaceuticals USA, Inc.
$73
Harmony Biosciences LLC
$63
Takeda Pharmaceuticals U.S.A., Inc.
$53
Circassia Pharmaceuticals Inc
$48
Jazz Pharmaceuticals Inc.
$47
Bayer Healthcare Pharmaceuticals Inc.
$37
Amgen Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$30
PFIZER INC.
$22
Avadel CNS Pharmaceuticals, LLC
$22
Philips North America LLC
$18
Covis Pharma GmBH
$17
Cumberland Pharmaceuticals, Inc.
$16
Genentech USA, Inc.
$16
Merck Sharp & Dohme Corporation
$13
ADVANCED RESPIRATORY, INC
$13
E.R. Squibb & Sons, L.L.C.
$12
Novartis Pharmaceuticals Corporation
$11
Top 3 companies account for 38.9% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Und · (8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · Arikayce · BELSOMRA · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · GLASSIA · Haegarda · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hizentra · INSPIRE · KEYTRUDA · Kcentra · LONHALA MAGNAIR · LUMRYZ · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · Spin · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · VERQUVO · Vibativ · Wakix · Wellcentive Undiv · XOLAIR · XYREM · XYWAV · Xembify · Xyrem · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
129
Per 100K population
10.1
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ehtesham is a clinical cardiology specialist, with above-average Medicare volume (top 29% in MI), with low-engagement industry engagement in the top 11% of MI peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ehtesham experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Ehtesham performed 251 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ehtesham receive payments from pharmaceutical companies?
Yes. Dr. Ehtesham received a total of $12,684 from 48 companies across 604 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ehtesham's costs compare to other pulmonary diseases in Farmington Hills?
Dr. Ehtesham's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ehtesham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Farmington Hills
Browse pulmonary diseases in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in MI
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in MI
Which MI pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Veran Medical Technologies, Inc. Payments to Doctors
See all physicians who received payments from Veran Medical Technologies, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology